Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1971 May 1;2(5756):270–272.

Chelating agents in medicine.

PMCID: PMC1796392  PMID: 4102017

Full text

PDF
270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BESSMAN S. P., RIED H., RUBIN M. Treatment of lead encephalopathy with calcium disodium versenate; report of a case. Med Ann Dist Columbia. 1952 Jun;21(6):312–315. [PubMed] [Google Scholar]
  2. Fielding J. Desferrioxamine chelatable body iron. J Clin Pathol. 1967 Jul;20(4):668–670. doi: 10.1136/jcp.20.4.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. MONCRIEFF A. A., KOUMIDES O. P., CLAYTON B. E., PATRICK A. D., RENWICK A. G., ROBERTS G. E. LEAD POISONING IN CHILDREN. Arch Dis Child. 1964 Feb;39:1–13. doi: 10.1136/adc.39.203.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Selander S., Cramér K., Hallberg L. Studies in lead poisoning. Oral therapy with penicillamine: relationship between lead in blood and other laboratory tests. Br J Ind Med. 1966 Oct;23(4):282–291. doi: 10.1136/oem.23.4.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Walshe J. M. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Lancet. 1969 Dec 27;2(7635):1401–1402. doi: 10.1016/s0140-6736(69)90940-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES